Arbutus Biopharma Corp’s recently made public that its Director MANCHESTER KEITH S unloaded Company’s shares for reported $32637.0 on Aug 14 ’24. In the deal valued at $3.69 per share,8,846 shares were sold. As a result of this transaction, MANCHESTER KEITH S now holds 46,069 shares worth roughly $0.16 million.
Then, Sims Karen sold 4,358 shares, generating $10,078 in total proceeds. Upon selling the shares at $2.31, the Chief Medical Officer now owns 125,542 shares.
Before that, HASTINGS DAVID C sold 9,593 shares. Arbutus Biopharma Corp shares valued at $22,184 were divested by the Chief Financial Officer at a price of $2.31 per share. As a result of the transaction, HASTINGS DAVID C now holds 181,907 shares, worth roughly $0.62 million.
Jefferies upgraded its Arbutus Biopharma Corp [ABUS] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in late February with a ‘”a Hold”‘ rating. H.C. Wainwright began covering ABUS with “Buy” recommendation on December 17, 2020.
Price Performance Review of ABUS
On Tuesday, Arbutus Biopharma Corp [NASDAQ:ABUS] saw its stock fall -1.45% to $3.41. Over the last five days, the stock has lost -0.29%. Arbutus Biopharma Corp shares have risen nearly 36.40% since the year began. Nevertheless, the stocks have risen 67.98% over the past one year. While a 52-week high of $4.72 was reached on 09/09/24, a 52-week low of $1.98 was recorded on 01/17/24. SMA at 50 days reached $3.80, while 200 days put it at $3.40.
Levels Of Support And Resistance For ABUS Stock
The 24-hour chart illustrates a support level at 3.36, which if violated will result in even more drops to 3.30. On the upside, there is a resistance level at 3.47. A further resistance level may holdings at 3.53. The Relative Strength Index (RSI) on the 14-day chart is 33.02, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.05, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.89%. Stochastics %K at 14.75% indicates the stock is a buying.
How much short interest is there in Arbutus Biopharma Corp?
A steep rise in short interest was recorded in Arbutus Biopharma Corp stocks on 2024-11-15, dropping by -1.74 million shares to a total of 6.06 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 7.79 million shares. There was a decline of -28.66%, which implies that there is a negative sentiment for the stock.
